Journal of Pharmaceutical Health Care and Sciences

Fig. 2 | Journal of Pharmaceutical Health Care and Sciences

Fig. 2

From: Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report

Fig. 2

ISSN: 2055-0294

Contact us

Submission enquiries: kathrina.mendez@springernature.com
General enquiries: journalsubmissions@springernature.com